|
|
|
13.01.26 - 01:48
|
Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...
|
|
|
|
|
|
|
30.12.25 - 14:36
|
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
|
|
|
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2025 financial results and respond to questions from financial analysts.
Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. Pre-registration for the webcast is available beginning today. A replay of the webcast will be made available on February 12, 2026.
About Zoetis
As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinari...
|
|
|
|
|
|
|
16.12.25 - 07:18
|
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering (Business Wire)
|
|
|
Substantially All of Net Proceeds Expected to Be Used to Repurchase Approximately $1.6 Billion of Common Stock and for Capped Call Transactions
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis has also granted the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $250 million aggregate principal amount of Notes. The offering is expected to close on December 18, 2025, subject to the satisfaction of customary closing conditions.
Use of Proceeds – Sh...
|
|
|
|
|
15.12.25 - 13:12
|
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering (Business Wire)
|
|
|
Substantially All Net Proceeds Expected to Be Used to Repurchase Common Stock and for Capped Call Transactions
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market conditions, it intends to offer $1.75 billion aggregate principal amount of convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $250 million aggregate principal amount of Notes.
Zoetis intends to use the net proceeds from the offering (i) to fund the cost of the capped call transactions described below; (ii) to purchase shares of Zoetis' common sto...
|
|
|
|
|
11.12.25 - 22:21
|
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase (Business Wire)
|
|
|
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% from the quarterly dividend rate paid in 2025. The dividend will be paid on Tuesday, March 3, 2026, to all holders of record of the Company's common stock as of the close of business on Tuesday, January 20, 2026.
About Zoetis
As the world's leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock producers. The company's leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in ...
|
|
|
|
|
05.12.25 - 02:06
|
Stocks Hold Steady as Meta Jumps on Deep Metaverse Cuts | The Close 12/4/2025 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Vanguard's Roger Hallam, PIMCO's Mohit Mittal, DA Davidson's Michael Baker, Zoetis' Kristin Peck, Moor Insights & Strategy's Patrick Moorhead, BlackRock's Amanda Lynam, MoviePass' Stacy Spikes, Your Rich BFF's Vivian Tu. (Source: Bloomberg)...
|
|
|
05.12.25 - 00:18
|
Zoetis CEO: Committed to Livestock Category (Bloomberg)
|
|
|
Kristen Peck, Zoetis CEO, says the company is committed to livestock, achieving its third consecutive year of above-market growth. She tells Romaine Bostick on “The Close” that Zoetis is focused on breeding healthier animals and providing vaccines and preventatives to keep them well. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
24.11.25 - 11:45
|
Zoetis: P/E auf Allzeittief (LYNX)
|
|
|
Während Investoren verunsichert sind, zeigt ein Blick auf die Fundamentaldaten von Zoetis eine ganz andere Realität. Die Gewinne steigen unaufhörlich....
|
|